NCT03729323 is a NA clinical trial of Motivational interviewing in Type 2 Diabetes Mellitus, sponsored by Hospital Nossa Senhora da Conceicao.

Who is sponsoring NCT03729323?

NCT03729323 is sponsored by Hospital Nossa Senhora da Conceicao.

What drugs are being tested in NCT03729323?

Interventions in NCT03729323: Motivational interviewing, Nursing Consultation.

What condition does NCT03729323 study?

NCT03729323 studies Type 2 Diabetes Mellitus, Systemic Arterial Hypertension.

Is NCT03729323 still recruiting?

NCT03729323 is currently completed. Last updated 16 March 2021.

Last reviewed 2021-03-16 · How we verify

NCT03729323

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Motivational Interviewing in the Control of Arterial Hypertension and Type 2 Diabetes Mellitus

Completed NA Last updated 16 March 2021

What this trial tests

NA trial testing Motivational interviewing in Type 2 Diabetes Mellitus in 189 participants. Completed in 12 March 2021.

Timeline

11 April 2018

Primary endpoint
20 June 2019

12 March 2021

Quick facts

Lead sponsor	Hospital Nossa Senhora da Conceicao
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	189
Start date	11 April 2018
Primary completion	20 June 2019
Estimated completion	12 March 2021
Sites	1 location across Brazil

Drugs / interventions tested

Motivational interviewing
Nursing Consultation

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Systemic Arterial Hypertension — all drugs for Systemic Arterial Hypertension →

Sponsor

Hospital Nossa Senhora da Conceicao

Who can join

18 and older, any sex, with Type 2 Diabetes Mellitus or Systemic Arterial Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to evaluate the effectiveness of Nursing Consultation based on the assumptions and techniques of Motivational Interviewing for the control of Type 2 diabetes mellitus with associated diagnosis of Systemic Arterial Hypertension in primary healthcare.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Motivational Interviewing in the Management of Type 2 Diabetes Mellitus and Arterial Hypertension in Primary Health Care: An RCT.
Steffen PLS, Mendonça CS, Meyer E, Faustino-Silva DD. · · 2021 · cited 19× · PMID 33637368 · DOI 10.1016/j.amepre.2020.12.015

Verify or expand the search:

Other trials of Motivational interviewing

Trials testing the same drug.

NCT07451496 — PRecision gerOMedicinE: Tailored Healthy agEing With Lifestyle, sUpplements and drugS (PROMETHEUS) · NA · recruiting
NCT06972030 — Motivational Interviewing-Based Training · NA · not yet recruiting
NCT06781216 — Effect of Motivational Interviewing on Posttraumatic Stress Symptoms and Posttraumatic Growth in Women with Endometrial · NA · not yet recruiting
NCT06635460 — Motivational Interviewing and WhatsApp-Based Monitoring for Metabolic Control and Self-Efficacy in Adolescents With T1DM · NA · not yet recruiting
NCT06583356 — Motivational Interviewing Intervention For Risky Drinking Treatment Among Indigenous Population · Phase 1, PHASE2 · not yet recruiting

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Hospital Nossa Senhora da Conceicao trials

Trials by the same sponsor.

NCT07426237 — Effect of the Addition of Adenosine on Myocardial Protection During Cardiopulmonary Bypass · Phase 4 · not yet recruiting
NCT07290647 — Prospective Validation of an Artificial Intelligence Tool for Pre-Anesthetic Assessment · not yet recruiting
NCT07067866 — Weaning Approaches for Vasopressin in Sepsis · Phase 3 · recruiting
NCT06404892 — ARISCAT, ASA and LAS VEGAS Risk Scores and the Incidence of Postoperative Pulmonary Complications in Thoracic Surgery · recruiting
NCT06466226 — Complications Associated With Multiple Central Venous Accesses in the Internal Jugular Vein · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03729323 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Nossa Senhora da Conceicao
Last refreshed: 16 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03729323.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing